Sihuan Pharmaceutical Holdings Group Ltd. (00460) carried out a repurchase of 15,000,000 ordinary shares on 17 October 2025 at prices ranging from HKD 1.43 to HKD 1.47, totaling HKD 21,757,500. The transaction increased the number of treasury shares from 161,011,000 to 176,011,000, with the total issued shares remaining at 9,329,999,206, of which 9,153,988,206 are in circulation.

Under the repurchase mandate approved on 06 June 2025, the company has bought back 59,596,000 shares in total, representing approximately 0.6468% of the issued shares as of the mandate's approval date. A moratorium period restricting new share issuances and treasury share disposals remains in effect until 16 November 2025.